Senzime AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNZZF research report →
About the company
Based in Uppsala, Sweden, Senzime AB (publ) is a medical technology company founded in 1999, specializing in the development and commercialization of advanced patient monitoring systems. These systems are designed to oversee individuals under anesthesia across a wide geographic reach, including Europe, Oceania, Asia, Canada, and the United States. A key offering is the TetraGraph monitor, which precisely stimulates, measures, analyzes, and displays muscle function for surgical patients administered neuromuscular blocking agents.
- CEO
- Philip Siberg
- IPO
- 2017
- Employees
- 54
- HQ
- Uppsala, SE
Price Chart
- Market Cap
- $75.24M
- P/E
- -5.31
- P/S
- 6.52
- P/B
- 2.38
- EV/EBITDA
- -7.22
- Div Yield
- 0.00%
- Gross Margin
- 31.03%
- Op Margin
- -116.31%
- Net Margin
- -120.74%
- ROE
- -38.32%
- ROIC
- -36.82%
- Revenue
- $103.76M · 77.44%
- Net Income
- $-137,074,273 · -15.45%
- EPS
- $-0.93 · 2.11%
- Op Income
- $-120,675,513
- FCF YoY
- 11.66%
- 52W High
- $0.74
- 52W Low
- $0.45
- 50D MA
- $0.48
- 200D MA
- $0.54
- Beta
- 0.40
- Avg Volume
- 8
Get TickerSpark's AI analysis on SNZZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SNZZF coverage
Recent articles, reports, and earnings notes.
No research on SNZZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNZZF report →Similar companies
Peers in the same neighborhood.